PROSTATE SCREENING: Big studies showed price of 20% cut in deaths is high
June 30, 2009 by Jim Tucker
JUNE 30: SCIENCE CODEX.COM: The two recently reported large randomised studies in Europe and the US illustrate that the price to pay for 20% reduction in prostate cancer deaths is high – over-diagnosis and over-treatment are great problems. The answers lie in improving the PSA test or finding biomarkers that effectively separate aggressive cancers from slow-growing ones. READ MORE>
Advertisement
Like this:
Be the first to like this post.
Posted in PROSTATE CANCER, PROSTATE RESEARCH, PSA tests, Screening debate, Treatment debate | Tagged 20% reduction in prostate cancer deaths, Biomarkers, cancer research, large randomised studies, over-diagnosis, Over-treatment, prostablog, prostate, PROSTATE CANCER, prostate treatment debate, prostate-specific antigen, PSA, PSA test, SCIENCE CODEX.COM, Screening debate, slow-growing | Leave a Comment
Leave a Reply
Prostablog RSS – click here
